SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 32 filers reported holding SCPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148,765 | -85.0% | 20,894 | -80.9% | 0.00% | – |
| Q1 2023 | $989,827 | +423.8% | 109,132 | +314.1% | 0.00% | – |
| Q4 2022 | $188,965 | -73.2% | 26,355 | -77.1% | 0.00% | – |
| Q2 2021 | $704,000 | -83.7% | 115,264 | -82.2% | 0.00% | -100.0% |
| Q1 2021 | $4,314,000 | +1954.3% | 648,770 | +1531.4% | 0.00% | – |
| Q4 2020 | $210,000 | -20.5% | 39,768 | +12.0% | 0.00% | – |
| Q3 2020 | $264,000 | +88.6% | 35,494 | +86.7% | 0.00% | – |
| Q2 2020 | $140,000 | +10.2% | 19,012 | +10.9% | 0.00% | – |
| Q1 2020 | $127,000 | +101.6% | 17,148 | +59.7% | 0.00% | – |
| Q3 2018 | $63,000 | -72.4% | 10,737 | -73.3% | 0.00% | – |
| Q2 2018 | $228,000 | -40.8% | 40,287 | +29.6% | 0.00% | – |
| Q1 2018 | $385,000 | -41.0% | 31,086 | -42.5% | 0.00% | – |
| Q4 2017 | $653,000 | – | 54,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,207,009 | $15,713,904 | 7.44% |
| 5AM Venture Management, LLC | 1,200,647 | $8,548,607 | 2.46% |
| Worth Venture Partners, LLC | 539,665 | $3,842,415 | 2.28% |
| COWEN AND COMPANY, LLC | 1,795,647 | $12,785,006 | 0.90% |
| Orbimed Advisors | 5,559,528 | $39,583,839 | 0.84% |
| Rubric Capital Management LP | 2,713,287 | $19,318,603 | 0.72% |
| AlphaCentric Advisors LLC | 125,000 | $890,000 | 0.50% |
| RTW INVESTMENTS, LP | 3,297,843 | $23,480,642 | 0.50% |
| Tejara Capital Ltd | 101,414 | $722,068 | 0.41% |
| Leucadia National | 745,550 | $5,308,316 | 0.05% |